AI assistant
AtriCure, Inc. — Director's Dealing 2014
Jan 29, 2014
31802_dirs_2014-01-28_ac2fcd75-26ee-482e-b7a0-24d1ff79a262.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2014-01-24
Reporting Person: Seith Douglas J (SVP, Sales and Marketing)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-01-24 | Common Stock | A | 30000 | $0.00 | Acquired | 89931 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-01-24 | Stock Option (right to buy) | $21.04 | A | 50000 | Acquired | 2024-01-24 | Common Stock (50000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3000 | Indirect |
Footnotes
F1: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2005 Equity Incentive Plan. The shares will vest 25% annually over four years from date of grant.
F2: The Reporting Person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.
F3: The option vests and is exercisable as to 25% of the shares one year from the date of grant, and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.
F4: Not applicable